Koen Augustyns

29PUBLICATIONS
92CO-AUTHORS
Biologically active moleculesMolecular targetsToxicology (incl. clinical toxicology)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 14, 2026
Correction to "Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP)".

|Jan 26, 2026
Vectorized ULK1/2 and VPS34 Inhibitors for Tissue-Selective Autophagy Inhibition in Oncology.

Lorenzo Cianni, Kathryn Jacobs, Sergei Grintsevich

|Oct 29, 2025
Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties.

Nicolò Filippi, Kathleen Mertens, Joni De Loose

|Oct 14, 2025
Structure-Property Investigation of New "KetoFAPI" Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic Potential.

Pawel Brzeminski, Emile Verhulst, Adrian Fabisiak

|Sep 18, 2025
Author Correction: Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.

Samya Van Coillie, Emily Van San, Ines Goetschalckx

|Sep 18, 2025
Biarylacetamides: a novel class of late-stage autophagy inhibitors.

Mélissa Lallier, Rani Robeyns, Freke Mertens

Pageof 5

Frequent Collaborators

14 joint publications

Pieter Van Der Veken

5 joint publications

Peter Vandenabeele

5 joint publications

Hans De Winter

5 joint publications

Tom Vanden Berghe